• Aghajanian, G. K., Bloom, F. E.: Localization of tritiated serotonin in rat brain by electromicroscopic autoradiography. J. Pharmacol. exp. Ther.156, 23–30 (1967)

  Google Scholar 

• Andén, N.-E., Carlsson, A., Haggendal, J.: Adrenergic mechanisms. Ann. Rev. Pharmacol.9, 119–134 (1969)

  Google Scholar 

• Ashcroft, G. W., Eccleston, D., Murray, L. G., Glen, A. I. M., Crawford, T. B. B., Pullar, I. A., Shields, P. J., Walter, D. S.: Modified amine hypothesis for the aetiology of affective illnesses. Lancet1972 II, 573–577

• Askew, B. M.: A simple screening procedure for imipramine-like antidepressant agents. Life Sci.10, 725–730 (1963)

  Google Scholar 

• Benesová, O., Náhunek, K.: Correlation between the experimental data from animal studies and therapeutical effects of antidepressant drugs. Psychopharmacologia (Berl.)20, 337–347 (1971)

  Google Scholar 

• Bevan, P., Bradshaw, C. M., Roberts, M. H. T., Szabadi, E.: The dual action of tricyclic antidepressant drugs on responses of single cortical neurons to acetylcholine. Brit. J. Pharmacol.49, 173P-174P (1973)

  Google Scholar 

• Blackwell, B., Lipkin, J. O., Meyer, J. H., Kuzma, R., Boulter, W. V.: Dose responses and relationships between anticholinergic activity and mood with tricyclic antidepressants. Psychopharmacoligia (Berl.)25, 205–217 (1972)

  Google Scholar 

• Bogdanski, D. F., Pletscher, A., Brodie, B. B., Udenfriend, S.: Identification and assay of serotonin. J. Pharmacol. exp. Ther.117, 82–88 (1956)

  Google Scholar 

• Bopp, B., Biel, J.: Antidepressant drugs. Life Sci.14, 415–423 (1974)

  Google Scholar 

• Bruinvels, J.: Evidence for inhibition of the re-uptake of 5-hydroxytryptamine and noradrenaline by tetrahydronaphthylamine. Brit. J. Pharmacol.42, 281–286 (1971)

  Google Scholar 

• Carlsson, A., Corrodi, H., Fuxe, K., Hökfelt, T.: Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-α-ethylmetatyramine. Europ. J. Pharmacol.5, 357–366 (1969a)

  Google Scholar 

• Carlsson, A., Corrodi, H., Fuxe, K., Hökfelt, T.: Effect of some antidepressant drugs on the depletion of intraneuronal brain catecholamines by 4-α-dimethyl-metatyramine. Europ. J. Pharmacol.5, 367–373 (1969b)

  Google Scholar 

• Carlsson, A., Jonason, J., Lindqvist, M., Fuxe, K.: Demonstration of extraneuronal 5-hydroxytryptamine accumulation in brain following membrane-pump blockade by chlorimipramine. Brain Res.12, 456–460 (1969c)

  Google Scholar 

• Consola, S., Ladinsky, H., Garattini, S.: Effect of several dopaminergic drugs and trihexyphenidyl on cholinergic parameters in the rat striatum. J. Pharm. Pharmacol.26, 275–277 (1974)

  Google Scholar 

• Coppen, A.: Indoleamines and affective disorders. J. Psychiat. Res.9, 163–171 (1972)

  Google Scholar 

• Ernest, A. M.: The role of biogenic amines in the extra-pyramidal system. Acta physiol. pharmacol. neerl.15, 141–154 (1969)

  Google Scholar 

• Everett, G. M.: The dopa response potentiation test and its use in screening for antidepressant drugs. In: Antidepressant drugs, S. Garattini and M. N. G. Dukes, eds., pp. 164–167. Amsterdam: Excerpta Medica Foundation 1967

  Google Scholar 

• Everett, G. M., Weigand, R. G.: Non-hydrazine monoamino oxidase inhibitors and their effects on central monoamines and motor behaviour. Biochem. Pharmacol.8, 85–92 (1962)

  Google Scholar 

• Everett, G. M., Weigand, R. G., Rinaldi, F. U.: Pharmacological studies of some non-hydrazine MAO inhibitors. Ann. N.Y. Acad. Sci.107, 1068–1080 (1963)

  Google Scholar 

• Fuxe, K., Ungerstedt, U.: Localization of 5-hydroxytryptamine uptake in rat brain after intraventricular injection. J. Pharm. Pharmacol.19, 335–337 (1967)

  Google Scholar 

• Garattini, S., Giachetti, A., Jori, A., Pieri, L., Valzelli, L.: Effect of imipramine, amitriptyline and their monomethyl derivatives on reserpine activity. J. Pharm. Pharmacol.14, 509–514 (1962)

  Google Scholar 

• Glowinski, J., Axelrod, J.: Effect of drugs on disposition of³H-norepinephrine in the rat brain. Pharmacol. Rev.18, 775–786 (1966)

  Google Scholar 

• Glowinski, J., Iversen, L. L.: Regional studies of catecholamines in rat brain. I. J. Neurochem.13, 655–669 (1966)

  Google Scholar 

• Halliwell, G., Quinton, R. M., Williams, F. E.: A comparison of imipramine, chlorpromazine and related drugs in various test involving autonomic functions and antagonism of reserpine. Brit. J. Pharmacol.23, 330–350 (1964)

  Google Scholar 

• Janowsky, D. S., El-Yousef, M. K., Davis, J. M., Sekerke, H. J.: Antagonistic effects of physostigmine and methylphenidate in man. Amer. J. Psychiat.130, 1370–1376 (1973)

  Google Scholar 

• Jori, A., Bernardi, D.: Importance of catecholamines for the interaction between reserpine and desimipramine on body temperature in rat. Pharmacology4, 235–241 (1970)

  Google Scholar 

• Kopin, I. J., Axelrod, J., Gordon, E.: The metabolic fate of³H-epinephrine and¹⁴C-metanephrine in the rat. J. biol. Chem.236, 2109–2113 (1961)

  Google Scholar 

• Kopin, I. J., Hertting, G., Gordon, E. K.: Fate of norepinephrine-³H in the isolated perfused heart. J. Pharmacol. exp. Ther.141, 321–325 (1962)

  Google Scholar 

• Lapin, I. P., Oxenkrug, G. F.: Intensification of the central serotonergic processes, possible determinant of the thymoleptic effect. Lancet1969 I, 132–136

  Google Scholar 

• Laverty, R., Taylor, K. M.: The fluorometric assay of catecholamine and related compounds. Analyt. Biochem.22, 269–279 (1968)

  Google Scholar 

• Lidbrink, P., Jonsson, G., Fuxe, K.: The effect of imipramine-like drugs and antihistamine drugs on uptake mechanisms in the central noradrenaline and 5-hydroxytryptamine neurons. Neuropharmacology10, 521–536 (1971)

  Google Scholar 

• Lippmann, W., Pugsley, T. A.: The effects of tandamine, a new potential antidepressant agent, on biogenic amine uptake mechanisms and related activities. Biochem. Pharmacol. (in press 1976)

• Maickel, R. P., Cox, R. H., Saillant, J., Miller, F. P.: A method for the determination of serotonin and norepinephrine in discrete areas of rat brain. Int. J. Neuropharmacol.7, 275–287 (1968)

  Google Scholar 

• Meek, J., Fuxe, K., Andén, N. E.: Effects of antidepressant drugs of the imipramine type on central 5-hydroxytryptamine neurotransmission. Europ. J. Pharmacol.9, 325–332 (1970)

  Google Scholar 

• Noble, E. P., Wurtman, R., Axelrod, J.: A simple and rapid method for injecting³H-norepinephrine into lateral ventricle of the rat brain. Life Sci.6, 281–291 (1967)

  Google Scholar 

• Pedersen, V.: Potentiation of apomorphine effect (compulsive gnawing behaviour) in mice. Acta pharmacol. (Kbh.)25, Suppl. 4, p. 63 (1967)

  Google Scholar 

• Pederson, V.: Role of catecholamines in compulsive gnawing behaviour in mice. Brit. J. Pharmacol.34, 219P-220P (1968)

  Google Scholar 

• Pletscher, A.: Monoamine oxidase inhibitors. Pharmacol. Rev.18, 121–129 (1966)

  Google Scholar 

• Plotnikoff, N., Will, F., Evans, A., Meekma, P.: PS-2747: A new antidepressant drug. Arch. int. Pharmacodyn.195, 330–342 (1972)

  Google Scholar 

• Pugsley, T. A., Lippmann, W.: Effect of butriptyline on the brain uptake mechanisms for noradrenaline and 5-hydroxytryptamine. J. Pharm. Pharmacol.26, 778–782 (1974)

  Google Scholar 

• Ross, S. B., Renyi, A. L., Ögren, S. O.: A comparison of the inhibitory activities of iprindole and imipramine on the uptake of 5-hydroxytryptamine and noradrenaline in brain slices. Life Sci.10, 1267–1277 (1971)

  Google Scholar 

• Ross, S. B., Renyi, A. L., Ögren, S. O.: Inhibition of the uptake of noradrenaline and 5-hydroxytryptamine by chlorphentermine and chlorimipramine. Europ. J. Pharmacol.17, 107–112 (1972)

  Google Scholar 

• Schildraut, J. J., Schanberg, S. M., Breese, G. R., Kopin, I. J.: Norepinephrine metabolism and drugs used in the affective disorders: a possible mechanism of action. Amer. J. Psychiat.124, 600–608 (1967)

  Google Scholar 

• Spencer, P. S. J.: The antagonism of oxotremorine effects in mouse by thymoleptics. Life Sci.5, 1015–1023 (1965)

  Google Scholar 

• Spencer, P. S. J.: Activities of centrally-acting and other drugs against tremor and hypothermia induced in mice by tremorine. Brit. J. Pharmacol.25, 442–455 (1966)

  Google Scholar 

• Sulser, F., Bickel, M. H., Brodie, B. B.: The action of desmethylimipramine in counteracting sedation and cholinergic effects of reserpine-like drugs. J. Pharmacol. exp. Ther.144, 321–330 (1964)

  Google Scholar 

• Ther, L., Schram, H.: Apomorphin-Synergismus (Zwangsnagen bei Mäusen) als Test zur Differenzierung psychotroper Substanzen Arch. int. Pharmacodyn.138, 302–310 (1962)

  Google Scholar 

• Van Praag, H. M.: Therapy-resistant depressions. Biochemical and pharmacological considerations. Pharmakopsychiat. Neuro-Psychopharmak.7, 88–97 (1974)

  Google Scholar 

• Vogt, M.: Functional aspects of the role of the catecholamines in the central nervous system. Brit. med. Bull.29, 168–171 (1973)

  Google Scholar 

• Von Euler, U. S., Floding, I.: Fluorometric determination of noradrenaline and adrenaline in urine. Acta physiol. scand.33, Suppl. 118, 45–47 (1955)

  Google Scholar 

• Whitby, L. G., Axelrod, J., Weil-Malherbe, H.: The fate of³H-norepinephrine in animals. J. Pharmacol. exp. Ther.132, 193–201 (1961)

  Google Scholar 

Download references